BioCentury | Oct 21, 2019
Company News

Oct. 21 Company Quick Takes: Vertex's triplet gains FDA approval; plus Bavarian Nordic-GSK, Farxiga, Ultomiris, Stelara

...Nordic acquires GSK vaccines Bavarian Nordic A/S (CSE:BAVA; Pink:BVNRY) gained global rights to RabAvert and Encepur...
...of the intestinal lining based on a new histologic-endoscopic mucosal improvement endpoint. BioCentury Staff Bavarian Nordic A/S GlaxoSmithKline plc Encepur...
Items per page:
1 - 1 of 1